Medicare Enrolled
Dr. Stanley Nabrinsky, MD
Hematology & Oncology · Elgin, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nabrinsky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nabrinsky?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nabrinsky
Dr. Stanley Nabrinsky is a hematology & oncology specialist in Elgin, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nabrinsky performed 148,892 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Nabrinsky received a total of $201,712 from 81 pharmaceutical and/or device companies across 755 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nabrinsky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 8% volume in IL
$201,712 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗148,892
Medicare services
Top 8% in IL for hematology & oncology
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
44,370 | $0 | $5 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
23,600 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 19,600 | $43 | $137 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
14,100 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
11,400 | $0 | $6 |
| Denosumab injection (Prolia/Xgeva) | 9,600 | $18 | $67 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
5,134 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
3,920 | $6 | $28 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,400 | $1 | $114 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,988 | $8 | $19 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,944 | $8 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,746 | $71 | $168 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
1,190 | $12 | $105 |
| Anti-nausea injection (ondansetron/Zofran) | 1,028 | $0 | $3 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
806 | $11 | $93 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
715 | $65 | $157 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
537 | $98 | $231 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
486 | $105 | $686 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
465 | $23 | $152 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
458 | $1 | $9 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
334 | $52 | $304 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
323 | $1 | $17 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
272 | $1 | $7 |
| Iron dextran injection, 50 mg An injection containing 50 mg of iron dextran administered to the patient. |
206 | $13 | $43 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
188 | $1 | $6 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
173 | $98 | $232 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 173 | $13 | $35 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
162 | $142 | $412 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
149 | $16 | $91 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
141 | $10 | $73 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
128 | $70 | $70 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
126 | $42 | $105 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
109 | $4 | $29 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
106 | $17 | $97 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
102 | $2 | $19 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
101 | $19 | $156 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
95 | $51 | $334 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
88 | $41 | $115 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
72 | $27 | $249 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
57 | $38 | $281 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
49 | $85 | $485 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
48 | $128 | $343 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
46 | $126 | $325 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
46 | $107 | $297 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
33 | $42 | $120 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
27 | $29 | $240 |
| New patient office visit, complex (60-74 min) | 23 | $181 | $432 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
17 | $146 | $523 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
11 | $32 | $56 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
31.0% high complexity
63.3% medium
5.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$201,712
Total received (2018-2024)
Avg $28,816/year across 7 years
Top 5% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
755
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$26,321
2023
$15,269
2022
$21,475
2021
$15,193
2020
$20,966
2019
$41,661
2018
$60,827
Payments by company (2024)
EMD Serono, Inc.
$10,867
AstraZeneca Pharmaceuticals LP
$7,521
BeiGene USA, Inc.
$2,643
Novartis Pharmaceuticals Corporation
$1,430
Genentech USA, Inc.
$1,185
E.R. Squibb & Sons, L.L.C.
$296
PFIZER INC.
$279
ABBVIE INC.
$215
Lilly USA, LLC
$214
SOBI, INC
$200
Celgene Corporation
$159
Astellas Pharma US Inc
$141
Merck Sharp & Dohme LLC
$117
Gilead Sciences, Inc.
$90
Takeda Pharmaceuticals U.S.A., Inc.
$70
SERVIER PHARMACEUTICALS LLC
$70
TerSera Therapeutics LLC
$64
Eisai Inc.
$62
Tempus AI, Inc
$60
Blueprint Medicines Corporation
$58
Incyte Corporation
$54
GENZYME CORPORATION
$51
Adaptive Biotechnologies Corporation
$49
Biocon Biologics Inc
$49
ARRAY BIOPHARMA INC
$44
Fennec Pharmaceuticals, Inc.
$29
Mirati Therapeutics, Inc.
$28
Agios Pharmaceuticals, Inc.
$26
Genmab U.S., Inc.
$25
GE HEALTHCARE
$25
Pharmacosmos Therapeutics Inc.
$25
Spectrum Pharmaceuticals Inc.
$25
GlaxoSmithKline, LLC.
$24
ACCORD HEALTHCARE, INC.
$22
Bayer Healthcare Pharmaceuticals Inc.
$22
Regeneron Healthcare Solutions, Inc.
$18
Alexion Pharmaceuticals, Inc.
$18
TAIHO ONCOLOGY, INC.
$16
Aveo Pharmaceuticals, Inc.
$16
Janssen Pharmaceuticals, Inc
$14
Top 3 companies account for 79.9% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$42,985
Gilead Sciences, Inc.
$18,528
Merck Sharp & Dohme Corporation
$16,954
Blueprint Medicines Corporation
$16,545
AstraZeneca Pharmaceuticals LP
$16,348
EMD Serono, Inc.
$10,982
Agios Pharmaceuticals, Inc.
$6,876
GENZYME CORPORATION
$6,674
PFIZER INC.
$5,985
Janssen Biotech, Inc.
$5,543
Novocure Inc.
$5,502
Kite Pharma, Inc.
$4,118
Epizyme, Inc.,
$3,281
CTI BioPharma Corp.
$2,797
BeiGene USA, Inc.
$2,663
Takeda Pharmaceuticals U.S.A., Inc.
$2,494
AMAG Pharmaceuticals, Inc.
$2,415
Coherus Biosciences Inc.
$2,300
Karyopharm Therapeutics Inc.
$1,980
Novartis Pharmaceuticals Corporation
$1,935
TAIHO ONCOLOGY, INC.
$1,831
GlaxoSmithKline, LLC.
$1,794
Immunocore Limited
$1,600
Incyte Corporation
$1,581
Eisai Inc.
$1,508
Celgene Corporation
$1,493
Exelixis Inc.
$1,447
Rigel Pharmaceuticals, Inc.
$1,241
Taiho Oncology, Inc.
$1,206
Puma Biotechnology, Inc.
$1,175
E.R. Squibb & Sons, L.L.C.
$993
Bayer HealthCare Pharmaceuticals Inc.
$981
Eagle Pharmaceuticals, Inc.
$850
Astellas Pharma US Inc
$722
Adaptive Biotechnologies Corporation
$705
ABBVIE INC.
$595
Lilly USA, LLC
$512
Daiichi Sankyo Inc.
$471
BeiGene, Ltd.
$450
Janssen Pharmaceuticals, Inc
$428
Pharmacosmos Therapeutics Inc.
$321
Seagen Inc.
$304
Merck Sharp & Dohme LLC
$290
SOBI, INC
$200
ModernaTX, Inc.
$188
Amgen Inc.
$143
Regeneron Healthcare Solutions, Inc.
$137
TerSera Therapeutics LLC
$135
Myriad Genetic Laboratories, Inc.
$111
ADC Therapeutics America, Inc.
$101
Cardinal Health 110 LLC
$100
SERVIER PHARMACEUTICALS LLC
$93
G1 Therapeutics, Inc.
$89
MorphoSys, US Inc.
$86
ARRAY BIOPHARMA INC
$85
EISAI INC.
$68
Spectrum Pharmaceuticals Inc.
$68
Secura Bio, Inc.
$64
Tempus AI, Inc
$60
Pharmacyclics LLC, an AbbVie Company
$53
Alexion Pharmaceuticals, Inc.
$50
Biocon Biologics Inc
$49
Clovis Oncology, Inc.
$44
Fennec Pharmaceuticals, Inc.
$29
Mirati Therapeutics, Inc.
$28
Genmab U.S., Inc.
$25
Myovant Sciences Inc.
$25
GE HEALTHCARE
$25
Pharmacyclics LLC, An AbbVie Company
$24
Organon LLC
$24
Mylan Institutional Inc.
$23
ACCORD HEALTHCARE, INC.
$22
Bayer Healthcare Pharmaceuticals Inc.
$22
Deciphera Pharmaceuticals Inc.
$20
Verastem, Inc.
$20
AbbVie Inc.
$20
ImmunoGen, Inc.
$17
Aveo Pharmaceuticals, Inc.
$16
PUMA BIOTECHNOLOGY, INC.
$15
AVEO Pharmaceuticals, Inc.
$15
Blue Earth Diagnostics Limited
$14
Top 3 companies account for 38.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · AYVAKIT · Alecensa · Aliqopa · Avastin · Axumin · BAVENCIO · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CALQUENCE · CAMCEVI · COSELA · CREON · Cabometyx · Columvi · Copiktra · ELAHERE · ELIQUIS · ELITEK · EMPLICITI · EPKINLY · ERLEADA · EXKIVITY · Elahere · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · Fulphila · GAZYVA · Hulio · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Itovebi · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Nubeqa · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · Oncology · PADCEV · PEMAZYRE · PEMFEXY · PIQRAY · PLUVICTO · PROMACTA · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · ROZLYTREK · RUXIENCE · Rezlidhia · Rituxan · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · TAGRISSO · TASIGNA · TECENTRIQ · TEPMETKO · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · Voranigo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · ZEJULA · Zoladex · Zydelig · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
95
County median income
$100,678
Nearest hospital to ZIP centroid (approximate)
ADVOCATE SHERMAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nabrinsky is a mixed practice specialist, with above-average Medicare volume (top 8% in IL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nabrinsky experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Nabrinsky performed 44,370 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Nabrinsky receive payments from pharmaceutical companies?
Yes. Dr. Nabrinsky received a total of $201,712 from 81 companies across 755 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nabrinsky's costs compare to other hematology & oncology specialists in Elgin?
Dr. Nabrinsky's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nabrinsky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Elgin
Browse hematology & oncology specialists in Elgin ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology